Leishmaniasis East African Platform (LEAP): Preparing the field for implementation

Abstract

This presentation describes the work of LEAP in evaluating, validating and registering improved treatment options for visceral leishmaniasis in the East African region, including summary results from a study of sodium stibogluconate, paromomycin and their combination, and plans for studies of amphotericin B and miltefosine.

Citation

Presentation from DNDiii’s 2nd Stakeholders’ Meeting & 3rd African Meeting, Nairobi, Kenya, 23 June 2009.

Leishmaniasis East African Platform (LEAP): Preparing the field for implementation

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.